We found an increased MKK7 and JNK activation in liver tissues from NAFLD mice, which was remarkably reduced by anti-TNFR1 but not by control-Ab treatment (Fig. 5a). This evidence concerns the gene TNFRSF1A and metabolic dysfunction-associated steatotic liver disease.